CRNX - Crinetics Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRNX is currently covered by 16 analysts with an average price target of $83.88. This is a potential upside of -$1.07 (-1.26%) from yesterday's end of day stock price of $84.95.

Crinetics Pharmaceuticals's activity chart (see below) currently has 173 price targets and 157 ratings on display. The stock rating distribution of CRNX is 94.29% BUY and 5.71% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 64.6% with an average time for these price targets to be met of 426.03 days.

Highest price target for CRNX is $97, Lowest price target is $67, average price target is $83.88.

Most recent stock forecast was given by JOSHUA SCHIMMER from CANTOR FITZGERALD on 02-Sep-2026. First documented stock forecast 13-Aug-2018.

Currently out of the existing stock ratings of CRNX, 33 are a BUY (94.29%), 2 are a HOLD (5.71%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 02-Sep-2026

1 months 10 days ago
(02-Sep-2026)

5/8 (62.5%)

$48.39 (116.29%)

407

Buy Since 02-Jul-2026

$85

$0.05 (0.06%)

$55

2 months 14 days ago
(28-Jul-2026)

1/2 (50%)

$1.14 (1.36%)

5

Buy Since 05-Jan-2026

$85

$0.05 (0.06%)

$90

3 months 4 days ago
(08-Jul-2026)

0/2 (0%)

$1.51 (1.81%)

Buy Since 13-Aug-2018

3 months 4 days ago
(08-Jul-2026)

5/5 (100%)

$26.41 (194.33%)

1556

Buy Since 07-Jul-2026

$85

$0.05 (0.06%)

$55

3 months 5 days ago
(07-Jul-2026)

1/2 (50%)

$1.47 (1.76%)

356

Show more analysts

Please expand the browser size to see the chart

What is CRNX (Crinetics Pharmaceuticals) average time for price targets to be met?

On average it took 426 days for the stock forecasts to be reached, with an average price target met ratio of 64.6%.

Which analyst most recently updated their price target on CRNX (Crinetics Pharmaceuticals)?

Josh Schimmer

Which analyst has the most public recommendations on CRNX (Crinetics Pharmaceuticals)?

Josh Schimmer works at CANTOR FITZGERALD and has 3 price targets and 3 ratings on CRNX

Which analyst is the currently most bullish on CRNX (Crinetics Pharmaceuticals)?

Yasmeen Rahimi with the highest potential upside of $60.3

Which analyst is the currently most reserved on CRNX (Crinetics Pharmaceuticals)?

Charles Duncan with the lowest potential downside of -$34.95
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?